Concepts (236)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Advance Care Planning | 11 | 2024 | 698 | 3.750 |
Why?
|
Palliative Care | 31 | 2024 | 3641 | 3.720 |
Why?
|
Emergency Service, Hospital | 43 | 2024 | 7871 | 3.100 |
Why?
|
Emergency Medicine | 12 | 2024 | 1220 | 2.780 |
Why?
|
Physicians | 10 | 2024 | 4593 | 1.570 |
Why?
|
Emergency Medical Services | 6 | 2023 | 1936 | 1.400 |
Why?
|
Communication | 17 | 2024 | 3904 | 1.300 |
Why?
|
Critical Illness | 7 | 2024 | 2753 | 1.150 |
Why?
|
Terminal Care | 8 | 2024 | 1770 | 1.080 |
Why?
|
Patient Care Planning | 3 | 2024 | 903 | 1.070 |
Why?
|
Physician-Patient Relations | 5 | 2024 | 3266 | 0.930 |
Why?
|
Nurse's Role | 2 | 2022 | 187 | 0.810 |
Why?
|
Out-of-Hospital Cardiac Arrest | 2 | 2023 | 341 | 0.800 |
Why?
|
Decision Making | 9 | 2024 | 3951 | 0.770 |
Why?
|
Love | 1 | 2021 | 39 | 0.750 |
Why?
|
Intubation, Intratracheal | 3 | 2019 | 1359 | 0.740 |
Why?
|
Respiratory Insufficiency | 2 | 2020 | 1240 | 0.730 |
Why?
|
Hospital Mortality | 4 | 2020 | 5345 | 0.710 |
Why?
|
Japan | 6 | 2024 | 1418 | 0.700 |
Why?
|
Hospital Rapid Response Team | 1 | 2020 | 54 | 0.670 |
Why?
|
Crisis Intervention | 1 | 2020 | 111 | 0.650 |
Why?
|
Dementia | 4 | 2024 | 2741 | 0.640 |
Why?
|
Hospice Care | 3 | 2024 | 678 | 0.620 |
Why?
|
Cardiopulmonary Resuscitation | 2 | 2023 | 996 | 0.620 |
Why?
|
Terminally Ill | 1 | 2020 | 240 | 0.600 |
Why?
|
Goals | 2 | 2022 | 717 | 0.570 |
Why?
|
Personal Autonomy | 1 | 2018 | 316 | 0.520 |
Why?
|
Dyspnea | 1 | 2024 | 1352 | 0.510 |
Why?
|
Aged | 39 | 2024 | 171319 | 0.500 |
Why?
|
Respiration, Artificial | 3 | 2023 | 2726 | 0.480 |
Why?
|
Aged, 80 and over | 21 | 2024 | 59548 | 0.450 |
Why?
|
Patient Participation | 2 | 2022 | 1444 | 0.430 |
Why?
|
Intensive Care Units | 3 | 2024 | 3797 | 0.430 |
Why?
|
Ambulatory Care | 3 | 2024 | 2780 | 0.430 |
Why?
|
Humans | 81 | 2024 | 767040 | 0.410 |
Why?
|
Caregivers | 5 | 2024 | 2302 | 0.390 |
Why?
|
Referral and Consultation | 5 | 2023 | 3618 | 0.370 |
Why?
|
Patient Preference | 1 | 2019 | 947 | 0.370 |
Why?
|
Hospices | 1 | 2023 | 245 | 0.340 |
Why?
|
Software Design | 1 | 2020 | 173 | 0.330 |
Why?
|
Medical Staff, Hospital | 2 | 2019 | 602 | 0.330 |
Why?
|
Family | 1 | 2020 | 3210 | 0.320 |
Why?
|
Attitude of Health Personnel | 3 | 2020 | 3928 | 0.320 |
Why?
|
Mortality | 2 | 2024 | 2909 | 0.320 |
Why?
|
Qualitative Research | 5 | 2024 | 3139 | 0.320 |
Why?
|
Male | 34 | 2024 | 364203 | 0.300 |
Why?
|
Feasibility Studies | 5 | 2022 | 5311 | 0.290 |
Why?
|
Cross-Sectional Studies | 9 | 2024 | 26325 | 0.280 |
Why?
|
Quality of Life | 5 | 2023 | 13485 | 0.270 |
Why?
|
Education, Medical, Graduate | 1 | 2018 | 2420 | 0.260 |
Why?
|
Nursing Staff, Hospital | 1 | 2019 | 350 | 0.260 |
Why?
|
Mass Screening | 2 | 2024 | 5456 | 0.250 |
Why?
|
Female | 31 | 2024 | 396660 | 0.250 |
Why?
|
Workflow | 1 | 2020 | 859 | 0.240 |
Why?
|
Death | 2 | 2023 | 685 | 0.230 |
Why?
|
Nurses | 1 | 2023 | 2501 | 0.220 |
Why?
|
Patient-Centered Care | 2 | 2024 | 1444 | 0.220 |
Why?
|
Hepacivirus | 6 | 2006 | 1342 | 0.210 |
Why?
|
Coronary Care Units | 1 | 2024 | 235 | 0.210 |
Why?
|
Medicare | 4 | 2024 | 6813 | 0.210 |
Why?
|
Pilot Projects | 4 | 2024 | 8732 | 0.200 |
Why?
|
Emergency Treatment | 2 | 2023 | 495 | 0.200 |
Why?
|
Communication Barriers | 2 | 2024 | 419 | 0.200 |
Why?
|
Telemedicine | 3 | 2020 | 3110 | 0.200 |
Why?
|
Prognosis | 6 | 2024 | 29963 | 0.190 |
Why?
|
Self Report | 2 | 2023 | 3773 | 0.180 |
Why?
|
Advance Directives | 1 | 2022 | 249 | 0.180 |
Why?
|
Risk Assessment | 2 | 2019 | 24299 | 0.180 |
Why?
|
Emergency Nursing | 1 | 2020 | 42 | 0.180 |
Why?
|
Decision Support Systems, Clinical | 1 | 2020 | 1178 | 0.180 |
Why?
|
Epitopes, T-Lymphocyte | 6 | 2006 | 827 | 0.180 |
Why?
|
Intubation | 1 | 2020 | 140 | 0.170 |
Why?
|
Middle Aged | 15 | 2024 | 223233 | 0.170 |
Why?
|
Awareness | 1 | 2024 | 653 | 0.170 |
Why?
|
Maine | 1 | 2019 | 146 | 0.160 |
Why?
|
Fee-for-Service Plans | 1 | 2024 | 713 | 0.160 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2024 | 10393 | 0.160 |
Why?
|
Long-Term Care | 1 | 2023 | 631 | 0.150 |
Why?
|
Pandemics | 5 | 2021 | 8736 | 0.150 |
Why?
|
Pneumoperitoneum | 1 | 2018 | 46 | 0.150 |
Why?
|
Hepatitis C | 6 | 2005 | 1594 | 0.150 |
Why?
|
Interviews as Topic | 3 | 2024 | 2741 | 0.150 |
Why?
|
Resuscitation Orders | 1 | 2020 | 271 | 0.150 |
Why?
|
Internship and Residency | 1 | 2018 | 5947 | 0.150 |
Why?
|
Home Care Services, Hospital-Based | 1 | 2018 | 44 | 0.150 |
Why?
|
United States | 11 | 2024 | 72971 | 0.150 |
Why?
|
Health Personnel | 2 | 2021 | 3387 | 0.140 |
Why?
|
CD8-Positive T-Lymphocytes | 6 | 2006 | 4648 | 0.130 |
Why?
|
Learning | 2 | 2023 | 1754 | 0.130 |
Why?
|
Telephone | 2 | 2021 | 629 | 0.130 |
Why?
|
Medical Records | 1 | 2021 | 1409 | 0.130 |
Why?
|
Hospitals, University | 1 | 2017 | 570 | 0.120 |
Why?
|
Hospitals, Urban | 1 | 2017 | 495 | 0.120 |
Why?
|
Health Communication | 1 | 2018 | 216 | 0.120 |
Why?
|
Hospitalization | 4 | 2024 | 10815 | 0.120 |
Why?
|
Area Under Curve | 1 | 2019 | 1639 | 0.120 |
Why?
|
Education, Medical, Undergraduate | 1 | 2023 | 1087 | 0.110 |
Why?
|
Perception | 1 | 2020 | 1205 | 0.110 |
Why?
|
Program Development | 1 | 2020 | 1298 | 0.110 |
Why?
|
Heart Arrest | 1 | 2023 | 1516 | 0.110 |
Why?
|
Retrospective Studies | 8 | 2024 | 81659 | 0.110 |
Why?
|
Video Recording | 1 | 2018 | 977 | 0.110 |
Why?
|
Home Care Services | 1 | 2019 | 659 | 0.100 |
Why?
|
Faculty, Medical | 1 | 2021 | 1227 | 0.100 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3112 | 0.100 |
Why?
|
Random Allocation | 1 | 2017 | 2394 | 0.100 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3234 | 0.100 |
Why?
|
Evidence-Based Medicine | 1 | 2024 | 3700 | 0.100 |
Why?
|
Prospective Studies | 5 | 2022 | 54886 | 0.100 |
Why?
|
Forecasting | 2 | 2022 | 2936 | 0.100 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2023 | 1481 | 0.100 |
Why?
|
Internal Medicine | 1 | 2019 | 1064 | 0.100 |
Why?
|
Information Dissemination | 1 | 2020 | 1142 | 0.100 |
Why?
|
Health Expenditures | 1 | 2024 | 2390 | 0.100 |
Why?
|
Physicians, Primary Care | 1 | 2018 | 623 | 0.100 |
Why?
|
Hospital Costs | 1 | 2018 | 956 | 0.100 |
Why?
|
ROC Curve | 1 | 2019 | 3618 | 0.090 |
Why?
|
Emotions | 1 | 2022 | 2760 | 0.090 |
Why?
|
Students, Medical | 1 | 2023 | 1965 | 0.090 |
Why?
|
Clinical Audit | 1 | 2019 | 29 | 0.080 |
Why?
|
Cohort Studies | 4 | 2023 | 41718 | 0.080 |
Why?
|
Severity of Illness Index | 2 | 2018 | 15925 | 0.080 |
Why?
|
Meningeal Neoplasms | 1 | 2018 | 1253 | 0.080 |
Why?
|
Health Services Research | 1 | 2016 | 1815 | 0.080 |
Why?
|
Patient Care Team | 1 | 2020 | 2516 | 0.080 |
Why?
|
Adult | 9 | 2024 | 223317 | 0.080 |
Why?
|
Primary Health Care | 2 | 2020 | 4746 | 0.080 |
Why?
|
Patient Compliance | 1 | 2018 | 2697 | 0.070 |
Why?
|
Internet | 1 | 2020 | 3114 | 0.070 |
Why?
|
Chronic Disease | 4 | 2018 | 9362 | 0.070 |
Why?
|
Neoplasm Metastasis | 1 | 2018 | 4892 | 0.070 |
Why?
|
New York | 1 | 2020 | 879 | 0.070 |
Why?
|
Viral Nonstructural Proteins | 2 | 2005 | 228 | 0.070 |
Why?
|
Multivariate Analysis | 1 | 2019 | 12069 | 0.060 |
Why?
|
Artificial Intelligence | 1 | 2020 | 2666 | 0.060 |
Why?
|
Feedback | 1 | 2019 | 797 | 0.060 |
Why?
|
HLA-B8 Antigen | 1 | 2004 | 16 | 0.060 |
Why?
|
Critical Care | 1 | 2018 | 2714 | 0.060 |
Why?
|
Immunodominant Epitopes | 1 | 2005 | 244 | 0.060 |
Why?
|
Quality Improvement | 2 | 2024 | 3854 | 0.060 |
Why?
|
Massachusetts | 1 | 2017 | 8890 | 0.060 |
Why?
|
Health Services | 1 | 2019 | 755 | 0.060 |
Why?
|
Inpatients | 1 | 2016 | 2563 | 0.060 |
Why?
|
Survival Rate | 1 | 2018 | 12823 | 0.050 |
Why?
|
Multicenter Studies as Topic | 1 | 2019 | 1733 | 0.050 |
Why?
|
Outpatients | 1 | 2021 | 1600 | 0.050 |
Why?
|
Hospitals | 1 | 2016 | 3883 | 0.050 |
Why?
|
Predictive Value of Tests | 1 | 2018 | 15424 | 0.050 |
Why?
|
Models, Biological | 1 | 2017 | 9464 | 0.040 |
Why?
|
Electronic Health Records | 1 | 2018 | 4881 | 0.040 |
Why?
|
Patient Acceptance of Health Care | 2 | 2024 | 3232 | 0.040 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2005 | 976 | 0.040 |
Why?
|
Physical Therapy Modalities | 1 | 2023 | 533 | 0.040 |
Why?
|
Consensus | 2 | 2022 | 3207 | 0.040 |
Why?
|
Health Care Costs | 2 | 2024 | 3239 | 0.040 |
Why?
|
New England | 1 | 2021 | 1058 | 0.040 |
Why?
|
Immunity, Cellular | 1 | 2004 | 1560 | 0.040 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2023 | 4054 | 0.040 |
Why?
|
Clinical Competence | 1 | 2024 | 4859 | 0.040 |
Why?
|
Hepatitis C, Chronic | 1 | 2006 | 1032 | 0.040 |
Why?
|
Algorithms | 1 | 2018 | 14098 | 0.040 |
Why?
|
Cost Control | 1 | 2019 | 627 | 0.040 |
Why?
|
Hospitals, Community | 1 | 2019 | 363 | 0.040 |
Why?
|
Patient Transfer | 1 | 2024 | 788 | 0.030 |
Why?
|
Heart Failure | 2 | 2019 | 11877 | 0.030 |
Why?
|
Acute Disease | 3 | 2019 | 7236 | 0.030 |
Why?
|
Geriatric Assessment | 1 | 2024 | 1422 | 0.030 |
Why?
|
Neoplasms | 2 | 2023 | 22350 | 0.030 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2004 | 2204 | 0.030 |
Why?
|
Cost-Benefit Analysis | 1 | 2019 | 5537 | 0.030 |
Why?
|
Quality of Health Care | 1 | 2020 | 4306 | 0.030 |
Why?
|
Remission, Spontaneous | 2 | 2005 | 384 | 0.030 |
Why?
|
Logistic Models | 1 | 2019 | 13284 | 0.030 |
Why?
|
Costs and Cost Analysis | 1 | 2019 | 1666 | 0.030 |
Why?
|
Psychometrics | 1 | 2023 | 3060 | 0.030 |
Why?
|
Antiviral Agents | 1 | 2005 | 3070 | 0.030 |
Why?
|
Policy | 1 | 2016 | 513 | 0.030 |
Why?
|
Delphi Technique | 1 | 2016 | 891 | 0.030 |
Why?
|
Needs Assessment | 1 | 2018 | 1141 | 0.030 |
Why?
|
Viremia | 2 | 2005 | 726 | 0.020 |
Why?
|
Boston | 1 | 2024 | 9360 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2018 | 21178 | 0.020 |
Why?
|
Length of Stay | 1 | 2024 | 6489 | 0.020 |
Why?
|
Curriculum | 1 | 2023 | 3786 | 0.020 |
Why?
|
Risk Factors | 1 | 2017 | 74886 | 0.020 |
Why?
|
Natural Language Processing | 1 | 2018 | 1202 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2019 | 2783 | 0.020 |
Why?
|
Lymphocyte Activation | 3 | 2005 | 5499 | 0.020 |
Why?
|
Health Services Needs and Demand | 1 | 2016 | 1405 | 0.020 |
Why?
|
Registries | 1 | 2023 | 8351 | 0.020 |
Why?
|
HIV-1 | 1 | 2004 | 6951 | 0.020 |
Why?
|
Viral Proteins | 2 | 2005 | 1801 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10582 | 0.020 |
Why?
|
T-Cell Antigen Receptor Specificity | 1 | 2005 | 89 | 0.020 |
Why?
|
Patient Readmission | 1 | 2019 | 3283 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2018 | 3488 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2023 | 20169 | 0.020 |
Why?
|
Mutation | 2 | 2006 | 30211 | 0.010 |
Why?
|
HLA-DR Antigens | 1 | 2005 | 609 | 0.010 |
Why?
|
Ribavirin | 1 | 2005 | 395 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2021 | 5363 | 0.010 |
Why?
|
Histocompatibility Testing | 1 | 2004 | 717 | 0.010 |
Why?
|
Hepatitis C Antigens | 1 | 2002 | 34 | 0.010 |
Why?
|
HLA-A2 Antigen | 1 | 2002 | 207 | 0.010 |
Why?
|
Cell Count | 1 | 2006 | 1825 | 0.010 |
Why?
|
Interferon-alpha | 1 | 2005 | 909 | 0.010 |
Why?
|
Selection, Genetic | 1 | 2006 | 877 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2018 | 7435 | 0.010 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2005 | 1442 | 0.010 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2016 | 3253 | 0.010 |
Why?
|
Amino Acid Substitution | 1 | 2004 | 1743 | 0.010 |
Why?
|
Polyethylene Glycols | 1 | 2005 | 1188 | 0.010 |
Why?
|
HLA Antigens | 1 | 2004 | 1334 | 0.010 |
Why?
|
Prevalence | 1 | 2016 | 15851 | 0.010 |
Why?
|
CD4 Lymphocyte Count | 1 | 2004 | 2586 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2023 | 65295 | 0.010 |
Why?
|
Up-Regulation | 1 | 2005 | 4143 | 0.010 |
Why?
|
Evolution, Molecular | 1 | 2004 | 1893 | 0.010 |
Why?
|
RNA, Viral | 1 | 2004 | 2867 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2005 | 6507 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2005 | 6310 | 0.010 |
Why?
|
Viral Load | 1 | 2004 | 3385 | 0.010 |
Why?
|
Adolescent | 1 | 2023 | 89046 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2002 | 3804 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2004 | 13411 | 0.010 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2005 | 4405 | 0.010 |
Why?
|
Biopsy | 1 | 2004 | 6777 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2004 | 17608 | 0.010 |
Why?
|
Liver | 1 | 2006 | 7578 | 0.010 |
Why?
|
Genotype | 1 | 2004 | 13035 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2005 | 18989 | 0.010 |
Why?
|
Peptide Fragments | 1 | 2002 | 5141 | 0.010 |
Why?
|
Genetic Variation | 1 | 2004 | 6611 | 0.010 |
Why?
|
Cytokines | 1 | 2004 | 7446 | 0.010 |
Why?
|
HIV Infections | 1 | 2004 | 17542 | 0.000 |
Why?
|
Animals | 1 | 2004 | 168965 | 0.000 |
Why?
|
Concepts
(236)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(80)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_